A recent study highlights metabolic and volumetric changes in the basal ganglia and cerebellum of individuals with dopa-responsive dystonia, including both symptomatic and asymptomatic GCH1 mutation carriers. These findings may enhance understanding of the disease's pathophysiology.
metabolic and volumetric alterations in the basal ganglia and the cerebellum in dopa responsive dystonia in symptomatic and asymptomatic gch1 mutation carriers
Original title: “Metabolic and Volumetric Alterations in the Basal Ganglia and the Cerebellum in Dopa-Responsive Dystonia in Symptomatic and Asymptomatic GCH1 Mutation Carriers.”